Ellis Andrea bought BBIO

March 4, 2026 · Form 4 insider transaction

Ellis Andrea bought 64,921 shares of BridgeBio Pharma, Inc. at $8.45 per share, a transaction worth $548.6K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
64,921
Price
$8.45
Total value
$548.6K
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 4, 2026
Filing dateMarch 6, 2026
Shares owned after83,510
OwnershipDirect
10b5-1 planNo
AmendedNo
View the original Form 4 on SEC EDGAR